高级检索
朱宝, 金双龙, 郭毅, 李月珍, 张奕华, 赖宜生. 吡啶类IRAK4抑制剂的设计、合成及生物活性评价[J]. 中国药科大学学报, 2017, 48(6): 670-674. DOI: 10.11665/j.issn.1000-5048.20170606
引用本文: 朱宝, 金双龙, 郭毅, 李月珍, 张奕华, 赖宜生. 吡啶类IRAK4抑制剂的设计、合成及生物活性评价[J]. 中国药科大学学报, 2017, 48(6): 670-674. DOI: 10.11665/j.issn.1000-5048.20170606
ZHU Bao, JIN Shuanglong, GUO Yi, LI Yuezhen, ZHANG Yihua, LAI Yisheng. Design, synthesis and biological evaluation of pyridine-based IRAK4 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 670-674. DOI: 10.11665/j.issn.1000-5048.20170606
Citation: ZHU Bao, JIN Shuanglong, GUO Yi, LI Yuezhen, ZHANG Yihua, LAI Yisheng. Design, synthesis and biological evaluation of pyridine-based IRAK4 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 670-674. DOI: 10.11665/j.issn.1000-5048.20170606

吡啶类IRAK4抑制剂的设计、合成及生物活性评价

Design, synthesis and biological evaluation of pyridine-based IRAK4 inhibitors

  • 摘要: 在现有IRAK4抑制剂MK-32和AU-5的基础上,利用开环策略和拼合原理,结合分子对接技术,设计并合成了12个以吡啶为基本母核的目标化合物。采用放射性同位素标记法评价了目标化合物对IRAK4激酶的抑制活性。结果表明,该类化合物对IRAK4显现出良好的抑制活性。其中5个化合物的IC50小于1 μmol/L,值得进一步研究。

     

    Abstract: Based on the known IRAK4 inhibitors MK-32 and AU-5, we designed and synthesized 12 pyridine-based target compounds by adopting open-ring and hybrid strategies, and combining molecular docking technology. The bioassays determined by radioisotope labeling demonstrated that the target compounds displayed good inhibitory activity against IRAK4. Among them, the IC50 value of 5 compounds was less than 1 μmol/L, suggesting that these compounds may be candidates for further investigation.

     

/

返回文章
返回